1. Home
  2. CHCI vs STXS Comparison

CHCI vs STXS Comparison

Compare CHCI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHCI

Comstock Holding Companies Inc.

HOLD

Current Price

$15.98

Market Cap

180.9M

Sector

Real Estate

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.81

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCI
STXS
Founded
1985
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
180.9M
190.6M
IPO Year
2004
2004

Fundamental Metrics

Financial Performance
Metric
CHCI
STXS
Price
$15.98
$1.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
9.0K
369.4K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
0.09
N/A
Revenue
$62,861,000.00
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
$176.44
N/A
Revenue Growth
22.55
N/A
52 Week Low
$9.73
$1.70
52 Week High
$19.72
$3.59

Technical Indicators

Market Signals
Indicator
CHCI
STXS
Relative Strength Index (RSI) 53.36 44.79
Support Level $15.24 $1.73
Resistance Level $17.35 $1.99
Average True Range (ATR) 0.93 0.09
MACD 0.09 -0.01
Stochastic Oscillator 87.72 18.57

Price Performance

Historical Comparison
CHCI
STXS

About CHCI Comstock Holding Companies Inc.

Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: